GERN
Geron Corporation
NASDAQ · Healthcare · Biotechnology · US
$1.57
+3.97%Forward multiples
Based on analyst estimates
- P/E forward
- 93.79x
- P/E 2026E
- —
- P/E 2027E
- 20.41x
- P/E 2028E
- 6.04x
- P/S forward
- 3.52x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.61x
- Price / sales
- 4.93x
- Price / cash flow
- -8.82x
Enterprise value
- Enterprise value
- $830.0M
- EV / sales
- 4.06x
- EV / EBITDA
- -19.88x
- EV / EBIT
- -22.19x
- Market cap
- $1.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026